3581 - 3590 of 9131 Results
Title
Year
-
OPENTitle: Integrated Representations of Threat and Controllability in the Lateral Frontal PoleJournal Name: Journal of Cognitive NeurosciencePublisher: MIT PressVol: 38Issue #: 5Start Page: 1000End Page: 1015Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/jocn.a.2418Best OA location URL: https://direct.mit.edu/jocn/article-pdf/doi/10.1162/JOCN.a.2418/2568466/jocn.a.2418.pdfCitation Count: 2
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
- Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting2020RESTRICTEDTitle: Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discountingJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 199Issue #:Start Page: 173070End Page: 173070Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2020.173070Citation Count: 10
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
-
OPENTitle: Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4Journal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 6Start Page: e2515002123End Page: e2515002123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2515002123Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2515002123Citation Count: 2
-
OPENTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3844End Page: 3855Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 2
-
OPENTitle: Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page: fcae146End Page: fcae146Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae146/57311805/fcae146.pdfCitation Count: 7
- DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease2024OPENTitle: DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 31End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-024-00421-0Best OA location URL: https://doi.org/10.1186/s40035-024-00421-0Citation Count: 23
-
OPENTitle: [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s DiseaseJournal Name: Neurology InternationalPublisher: MDPI AGVol: 16Issue #: 2Start Page: 419End Page: 431Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/neurolint16020031Best OA location URL: https://www.mdpi.com/2035-8377/16/2/31/pdf?version=1712582537Citation Count: 12
-
OPENTitle: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page: 403End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03914-7Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03914-7Citation Count: 3